IMS: Efemia sales up 40% in H1 2024, narrowing losses but more capital needed for growth

About this update from Invent Medic Sweden Ab

Efemia Bladder Support sales surged over 40% in H1 2024, offsetting FlowCup's e-commerce decline. Losses narrowed year-over-year, but additional capital is needed before reaching cash flow positivity.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Invent Medic Sweden Ab